home / stock / ebs / ebs articles

EBS Articles, Emergent Biosolutions Inc.

Stock Information
Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com
Menu
EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings | Benzinga

Johnson & Johnson (NYSE:JNJ) will release its second-quarter financial results, before the opening bell on Wednesday, July 17. Analysts expect ...
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs | Benzinga

U.S. pharma giant Johnson & Johnson (NYSE:JNJ) will report its second-quarter 2024 earnings on Wednesday, July 17. As per data from Benzinga Pr...

Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED) | Benzinga

Editor’s Note: The story has been updated to replace the erroneous content published earlier. Tuesday, Emergent BioSolutions Inc. (NYSE:EBS...

Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? | Benzinga

Nvidia Corp (NASDAQ:NVDA) is trading lower Tuesday amid reports that the company faces antitrust charges from French regulators. These charges foll...
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products | Benzinga

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced it has received more than $250 millio...

What Is Going On With Emergent BioSolutions Shares? | Benzinga

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bo...

Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million | Benzinga

GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into a definitive...
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day | Benzinga

Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard of care for opioid overdose reversal in a commu...

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 | Benzinga

GAITHERSBURG, Md., May 10, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that its 2024 Annual Meeting of Stock...

Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock? | Benzinga

Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial pos...
Next 10